Profhilo stabilised hybrid cooperative complexes is the first product developed with Nahyco hybrid technology. It is available in 43 countries and has received Amec and Aesthetics Awards.
Profhilo intervenes in the dermal tissue repair process, in cases of acne or scars. The physiological process of ageing tissue, in presence of alterations in elastic fibres and collagen. As well as, in cases of loss or compromised adipose tissue. Tissue remodelling is easily obtained in only two sessions (4-week interval), using all aesthetic injection techniques, in the superficial subcutaneous layer.
70% of subjects show an improvement of at least one grade according to the FVLS (Facial Volume Loss Scale Range 2-3). Significant improvement in skin hydration after only one treatment and in skin elasticity after two treatments. Significant improvement of satisfaction levels after the second treatment.
Profhilo represents an intriguing new paradigm for skin restoration and improvement of skin laxity. It is the:
– first injectable hyaluronic acid for skin remodelling and treating skin laxity
– first stabilised product without the use of BDDE (thermal process)
Profhilo has been hailed as “a true breakthrough in anti-ageing medicine”, “a major advance for difficult to treat areas” or “a real game-changer” to name a few…
Treatments are carried out at Medispa (Cheshire, Liverpool & Harley Street, London), arrange your free consultation by calling 0800 009 6661 or booking online.
Please note, prices are different across doctors and nurses.
It is suitable for all skin types.
40-50 year olds are indicated for Profhilo, but as we have shown it is also really effective with younger and older patients. The minimum age for Profhilo treatment is 30.
The use of the bap technique identifies the 5 anatomically receptive areas of the face with an absence of large vessels and nerve branches, therefore, minimising the risks while maximising the diffusion of the product in the malar and submalar areas. 0.2ml of Profhilo is then injected at the superficial subcutaneous layer.
As with any injectable there are minor risks including bruising and swelling, as well as infection, allergic reaction, vascular compromise and nerve damage; although IBSA claims these are rare.
After four weeks patients reported having improvement in lines and tightness of their skin. After eight weeks there was a definite lifting and tightening in the skin.
At the beginning you will receive two treatments with a one month interval, followed by a maintenance treatment after two months depending on the level of aging. Effects will last for six months.
You can get treatment on your face, neck, décolleté, hands, and arms.
NEITHER. Profhilo is something new and indicated for skin bioremodeling. Therefore, defining Profhilo in either of these two areas is a losing strategy.